FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer

Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic effect of chemotherapy is limited due to the resistance of cancer cells, which remains a challenge in cancer therapeutics. In this work, we found that flap endonuclease 1 (FEN1) is overexpressed in lung cancer ce...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Oncol
Glavni autori: He, Lingfeng, Luo, Libo, Zhu, Hong, Yang, Huan, Zhang, Yilan, Wu, Huan, Sun, Hongfang, Jiang, Feng, Kathera, Chandra S., Liu, Lingjie, Zhuang, Ziheng, Chen, Haoyan, Pan, Feiyan, Hu, Zhigang, Zhang, Jing, Guo, Zhigang
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5467497/
https://ncbi.nlm.nih.gov/pubmed/28371273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12058
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items